Veterinary Diagnostics Market Size Analysis, Growth Trends & Forecast to 2034

Veterinary Diagnostics Market Overview

The global veterinary diagnostics market was valued at USD 8.2 billion in 2026 and is projected to reach USD 15.9 billion by 2034, expanding at a CAGR of 9.2% during the forecast period. The market for veterinary diagnostics includes equipment, reagents, materials, software, and laboratory services that are involved in the detection, monitoring, and management of disease in companion and livestock animals. Diagnostic tools like immunodiagnosis, molecular diagnostics, hematology, clinical biochemistry, microbiology, and point-of-care tests are responsible for ensuring early detection, diagnosis, and treatment of disease conditions. There are factors such as an increased number of pets, increasing expenditure on animal healthcare, increased production of livestock, and the prevalence of zoonotic diseases that influence the market. There are also improvements in technologies like molecular diagnostics, automation, artificial intelligence-based diagnostics, and rapid point-of-care tests that improve the effectiveness of diagnoses.

Veterinary Diagnostics Market Drivers and Opportunities

Rising Pet Ownership and Increasing Animal Healthcare Expenditure Are Driving Market Growth

 The growth in the population of those who own companion animals and the growth in the expenditure on pet health care services form one of the major reasons for the demand for veterinary diagnostic tests in the market. As per the statistics from the most recent sourcebook from the AVMA, the number of households that own any pets rose from 71.5 million in 2016 to 77.5 million in 2025, and 58.6% of the total households have at least one pet. Meanwhile, the number of dogs that were owned rose from 76.8 million to 87.3 million, while the number of cats that were owned rose from 58.3 million to 76.3 million in the same duration of time. The report mentions that the relationship between man and animals has grown very close, as more than 79.5% of dog owners and 70.4% of cat owners regard their pets as part of their families.

As more pets become a part of the family unit, expenditure on basic veterinary care, disease detection, vaccination, and treatment of chronic diseases is steadily increasing. Pet owners are putting increased focus on early diagnosis and regular check-ups to improve their pet's health and increase their lifespan. Such developments are driving more veterinary facilities to adopt newer veterinary diagnostic equipment such as immunodiagnostics kits, molecular diagnostics, clinical chemistry instruments, point-of-care instruments, and other diagnostic tests performed in the laboratory. These developments are expected to drive the market for veterinary diagnostics over the forecast period due to increased pet ownership and healthcare expenditure.

Growing Focus on Livestock Health and Zoonotic Disease Surveillance Fueling Market Expansion

With the rising demand for animal-based food items, such as meat, milk, and eggs, there have been increasing investments made in health management and disease prevention among livestock, thus offering a lot of potential for the growth of the veterinary diagnostics market. Livestock farmers are focusing more on keeping their herd healthy, minimizing losses, and making effective use of feed by means of disease monitoring and preventive health care services. It has become necessary to diagnose infectious diseases like foot and mouth disease, avian flu, African swine fever, bovine tuberculosis, and brucellosis to reduce any economic losses or prevent disease outbreaks, thus ensuring continuous production from the livestock. On the other hand, the increasing threat of zoonotic diseases coupled with concerns over global food security issues has led to the improvement of animal disease surveillance systems. Advanced diagnostics have been vital for monitoring the occurrence of disease outbreaks, conducting epidemiological research, adopting fast reaction strategies, and complying with animal health and food safety guidelines. The emerging technologies in molecular diagnostics, PCR-based tests, immunodiagnosis, and portable point-of-care testing have assisted in faster and more accurate detection of pathogens. Furthermore, continuous development in laboratory facilities, livestock disease surveillance systems, and One Health initiatives will result in an increasing adoption of advanced diagnostic techniques, which is anticipated to boost the global veterinary diagnostics market.

Expansion of Point-of-Care and AI-Enabled Veterinary Diagnostics Presents Significant Opportunities

The increasing need for speedy, reliable, and decentralized diagnostic tests is opening up a significant number of business opportunities in the point-of-care (POC) and artificial intelligence-driven veterinary diagnostic market. The use of portable analyzers and small diagnostic systems that provide quick and reliable results within minutes is becoming increasingly common among veterinarians, allowing for faster decision-making and prompt commencement of treatments. Such technologies decrease dependency on laboratory settings, improve efficiency of workflows, and increase availability of diagnostic services in veterinary clinics, livestock farms, mobile veterinary services, and remote areas. Cloud-based diagnostic systems allow for easy sharing of information and consultation from remote places.

Through improvements in the speed, accuracy, and consistency of test interpretation, artificial intelligence is changing the dynamics of veterinary diagnostics. Image analysis powered by AI and automated hematology systems has proven to be effective in reducing human errors, simplifying laboratory practices, and assisting veterinarians in the diagnosis of complicated diseases. Indeed, it is against this background that the enhancement of Vetscan OptiCell by Zoetis Inc., the company's cartridge-based artificial intelligence-powered hematology analyzer, was announced in April 2026. It represents the next stage of the development of the platform. Designed for fast and accurate blood testing, this system will facilitate veterinary experts' decision-making. Such advances in veterinary diagnostics represent a move towards intelligent and connected devices that allow for point-of-care testing. The increasing use of AI and related technologies in the veterinary sector and their ability to improve the accuracy of diagnoses and the efficiency of work routines are likely to bring substantial growth prospects for the global veterinary diagnostics market during the forecast period.

Veterinary Diagnostics Market Scope

Veterinary Diagnostics Market Report Segmentation Analysis

The global veterinary diagnostics market industry analysis is segmented by product type, by technology, by animal type, by end user, and by region.

Kits and Reagents Segment Is Expected to Dominate the Veterinary Diagnostics Market During the Forecast Period

The kits and reagents category will occupy the largest portion of the veterinary diagnostics market share during the forecast period due to their repeated usage, wide application areas, and the rising need for quick and accurate diagnosis. While diagnostic instruments are capital goods, kits and reagents are considered consumable products that will continue to be used for every single test done. The increasing number of health screening tests, infectious disease testing, clinical chemistry testing, immunodiagnostics testing, molecular diagnostics testing, hematology testing, and parasitology testing among pets and livestock is leading to increased use of these products. Increased pet ownership, growth in livestock production, and increased awareness about preventive animal healthcare are adding to the increase in testing volume. Technological innovations are another factor supporting the development of this market segment. New types of highly sensitive, user-friendly, and fast diagnostic assays are introduced by manufacturers, providing veterinarians with the ability to receive precise results in just a few minutes. Furthermore, the adoption of PCR-based reagents, ELISA kits, multiplex diagnostic tests, and cartridges for diagnostics is contributing to increased efficiency of the process and decreased turnaround times. Expansion of veterinary clinics and in-house laboratories, along with the growing monitoring of zoonoses and livestock diseases, is further facilitating the increased use of reagents. Finally, continuous innovation of products by leading animal health companies and a preference for decentralization of testing are predicted to continue supporting the demand for diagnostic kits and reagents, ensuring dominance of this segment in the global veterinary diagnostics market.

Immunodiagnostics Segment Is Expected to Lead the Veterinary Diagnostics Market by Technology

The immunodiagnostics segment will continue to lead the veterinary diagnostics market in the forecast period on account of the extensive use of these tests in the diagnosis of various infectious diseases, endocrine diseases, and other diseases of animals with speed and accuracy. Technologies like ELISA, lateral flow tests, and antigen and antibody tests are highly sensitive and inexpensive; hence, they are the preferred mode of tests in veterinary hospitals, veterinary clinics, diagnostic labs, and livestock farms.

Increasing demand for preventive healthcare of animals, rising cases of zoonosis and infectious diseases, and increased wellness testing are increasing the demand for immunodiagnostic technologies. Moreover, advances in multiplex assays and point-of-care immunodiagnostics are increasing their effectiveness and availability in the global veterinary diagnostics market.

Companion Animals Segment Is Expected to Dominate the Animal Type Segment

The pets’ companion animal category will remain dominant in the global veterinary diagnostics industry throughout the forecast period owing to increased pet ownership, higher humanization of pets, and greater investment in preventive healthcare. Increasing demand for health screenings, disease diagnosis, and disease management in companion animals, including dogs, cats, and others, is promoting the application of veterinary diagnostic procedures. Moreover, the growing usage of point-of-care, molecular, and immunodiagnostics in veterinary hospitals and clinics will help the segment maintain its market dominance.

Veterinary Hospitals & Clinics Segment Is Expected to Dominate the End User Segment

The veterinary hospitals & clinics category is anticipated to lead the veterinary diagnostics market throughout the forecast period on account of the rising number of pet visits, increasing requirement for preventative healthcare, and growing usage of innovative diagnostic equipment. Veterinary hospitals & clinics act as the main venue for health screening and disease diagnoses, resulting in the widespread use of diagnostic devices, imaging equipment, molecular diagnostics, and point-of-care testing systems.

Further expansion in the development of veterinary hospitals and enhanced focus on clinical services is also contributing towards the growth of the segment. For example, in February 2026, CareVet introduced its Premier Centers, which represent a network of hospitals known for their clinical excellence and veterinary practices based on evidence, thereby promoting the usage of advanced diagnostic equipment. In June 2026, Lakefield Veterinary Group introduced the Care Beyond Limits Fund, which aims at providing necessary veterinary services to pets that cannot afford to pay for them due to a lack of funds.

The following segments are part of an in-depth analysis of the global veterinary diagnostics market:

Veterinary Diagnostics Market Share Analysis by Region

North America is projected to hold the largest share of the global veterinary diagnostics market over the forecast period  

North America is projected to hold the largest share of the global veterinary diagnostics market due to the following factors: a high number of pets, modern veterinary healthcare facilities and services, strong livestock health management practices, and the presence of key players in the animal health sector. Other factors contributing to the region’s market share include increasing adoption of advanced technology solutions, rising healthcare costs for companion animals, and the presence of numerous veterinary hospitals, clinics, and diagnostic labs.

Moreover, strategic investments and acquisitions carried out by key players consolidate North America's market leadership position. For example, in March 2026, Zoetis Inc. entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for USD 160 million. This merger enhances Zoetis’ portfolio in precision animal health and genomics and expands its global diagnostics portfolio with Neogen’s genomics business that serves customers in more than 120 countries through its laboratories in the US, Brazil, Australia, China, and the UK.

Veterinary Diagnostics Market Competition Landscape Analysis

The market for veterinary diagnostics is a very competitive one, with the leading companies operating in the segment of animal health, veterinary diagnostics manufacturing, and biotechnology concentrating on the development of novel diagnostic technologies for companion and livestock animals. The market players are engaged in developing advanced immunodiagnostic, molecular diagnostic, point-of-care, clinical chemistry, hematology, and AI-based diagnostic technologies that will help detect diseases fast and accurately. Acquisitions, collaborations, launching new products, geographical expansion, and R&D are the ways market players are building up their market position. Moreover, the increasing use of rapid diagnostic tests, integration of AI and digital veterinary solutions, livestock disease surveillance programs, and preventive care for animal health are the factors contributing to the growth of the market. 

Global Veterinary Diagnostics Market Recent Developments News:

●        In May 2026 – HORIBA announced the launch of Yumivet, its new veterinary diagnostics brand, alongside the introduction of a dedicated solution, the Yumivet VH2500 hematology analyzer.

●        In January 2026 - Antech, a global veterinary diagnostics company, announced the launch of RapidRead Dental for Feline, an AI-powered dental radiograph analysis solution built specifically for cats, and the addition of SDMA testing to its in-house diagnostic platform, Element i+.

●        In November 2025 - Zoetis Inc. announced the acquisition of Veterinary Pathology Group, a leading veterinary diagnostic laboratory group with multiple locations across the UK and Ireland. The acquisition further expands Zoetis’ comprehensive diagnostics portfolio and reinforces its commitment to advancing animal health through innovative, high-quality diagnostic solutions.

●        In September 2025 - FUJIFILM Healthcare Europe announced the European launch of the FUJI DRI-CHEM AU20V, an enhanced in-house diagnostics measurement device for veterinary use.

The Global Veterinary Diagnostics Market is dominated by a few large companies, such as

●        BioMérieux SA

●        BioNote Inc.

●        Bio-Rad Laboratories Inc.

●        Boehringer Ingelheim GmbH

●        Covetrus Inc.

●        Danaher Corporation

●        Esaote SpA

●        Eurofins Technologies

●        Heska Corporation

●        HIPRA

●        IDEXX Laboratories Inc.

●        IDVet

●        INDICAL Bioscience GmbH

●        Mindray Medical International Ltd.

●        Neogen Corporation

●        QIAGEN N.V.

●        Randox Laboratories Ltd.

●        Thermo Fisher Scientific Inc.

●        Virbac SA

●        Zoetis Inc.

●        Other Prominent Players